Alisa Wolberg: Thrilled to Have Been Able to Visit the NIH with ASH and Advocate for Science and the Fight 4 Hematology
Alisa Wolberg, Professor at University of North Carolina at Chapel Hill, reposted from ASH on LinkedIn:
”Thrilled to have been able to visit the NIH with ASH last week and advocate for science and the Fight 4 Hematology”
American Society of Hematology (ASH) shared on LinkedIn:
”Last week, ASH leaders went to The National Institutes of Health (NIH) to advocate for blood research.
Drs. Belinda Avalos, Robert Negrin, Jennifer Brown, and Alisa Wolberg met with NIH and NHLBI leaders to discuss critical priorities in hematology.
Key topics included:
- Protecting federal funding for hematology research
- Supporting early-career investigators through the Fight 4 Hematology campaign
- Updates on NIH peer review and other policy changes that impact research and patient care
These conversations are vital for ensuring hematology research continues to advance, patients benefit from breakthroughs, and the next generation of hematologists is supported.
Learn how you can Fight 4 Hematology.”
Stay updated with Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target